Exosomal donor cells were engineered to secrete GE11 peptide modified exosomes (GE11-exosomes), and the tumor inhibitory miRNA was transferred to breast cancer tissue with high expression of EGFR by exosomes [110]. This evidence concerns the gene EGFR and breast carcinoma.